GlassScriptPhysician profile
Prasad Chalasani
NPI 1760477269
$8,241.49
in general payments reported to CMS, 2019-2025
15 companies · $647 in 2025
The $647 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $994 · 2020: $36.40 · 2021: $376 · 2022: $1,807 · 2023: $506 · 2024: $3,876 · 2025: $647.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,454 · Food and Beverage: $2,090 · Consulting Fee: $485.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,453.70 |
| Food and Beverage | $2,089.76 |
| Consulting Fee | $485.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,896.02 | 2019-2025 | Aveir, Amplatzer Amulet |
| Medtronic, INC. | $2,992.68 | 2021-2025 | Corevalve Evolut R, Onyx Frontier, Symplicity G3 |
| Boston Scientific Corporation | $683.48 | 2020-2025 | Watchman Flx, Watchman Access System, Rotapro |
| Edwards Lifesciences Corporation | $218.27 | 2021-2023 | Sapien 3 Ultra Resilia |
| Glaxosmithkline, LLC. | $124.76 | 2022 | |
| Pfizer INC. | $101.21 | 2022-2024 | |
| Kestra Medical Technology Services, INC. | $56.35 | 2024-2025 | Assure Wcd |
| Medtronic Vascular, INC. | $41.58 | 2019-2020 | |
| Acist Medical Systems, INC. | $37.18 | 2022 | |
| Cvrx, INC. | $33.97 | 2023 | Barostim Neo System |
| Cordis US Corp. | $22.21 | 2023 | Infiniti |
| Abiomed | $19.89 | 2024 | Impella |
| Astrazeneca Pharmaceuticals LP | $13.89 | 2022 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Prasad Chalasani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.